• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单灶性腹膜间皮瘤的罕见病例:病例报告、文献综述及未来研究方向

The rare occurrence of unifocal peritoneal mesothelioma: a case report, literature review, and future directions.

作者信息

Ghabra Shadin, Dinerman Aaron J, Sitler Collin A, Ahn Diane, Joyce Stacy R, Satterwhite Audra, Sullivan Molly A, Blakely Andrew M

机构信息

Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

出版信息

J Gastrointest Oncol. 2024 Aug 31;15(4):1939-1947. doi: 10.21037/jgo-24-266. Epub 2024 Aug 20.

DOI:10.21037/jgo-24-266
PMID:39279939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11399855/
Abstract

BACKGROUND

Mesothelioma is a rare, aggressive disease originating from mesothelial cells and carries a poor prognosis. Mesothelioma may arise from the pleura, pericardium, or peritoneum. Peritoneal mesothelioma (PM) usually spreads in a diffuse manner; however, a localized unifocal form of PM may occur. Literature on unifocal mesothelioma remains scarce.

CASE DESCRIPTION

Herein, we highlight a case of localized epithelioid PM in an 81-year-old gentleman with the unique challenges faced during management. The pelvic mass was 7 cm, well-circumscribed, and hyper-vascular with fibrous attachments to the abdominal wall. The patient had a peritoneal cancer index (PCI) of 4 on initial diagnostic laparoscopy. Diagnosis was confirmed by histology. Resection of the mass with a partial omentectomy was performed. Months later, the patient developed recurrence detected on follow-up imaging in the peri-splenic region. The patient underwent cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) for 60 minutes using mitomycin C and cisplatin followed by an uneventful recovery. Our case report is followed by a review of literature on disease pathophysiology, treatment options, and recently promising immunotherapy approaches.

CONCLUSIONS

CRS and HIPEC remains the standard treatment regimen for patients with PM. Nonetheless, a more nuanced approach might be indicated in specific patients with localized unifocal PM. Disease distribution and burden may impact the decision on surgical management in selected patients.

摘要

背景

间皮瘤是一种罕见的侵袭性疾病,起源于间皮细胞,预后较差。间皮瘤可起源于胸膜、心包或腹膜。腹膜间皮瘤(PM)通常以弥漫方式扩散;然而,也可能出现局部单灶性的PM。关于单灶性间皮瘤的文献仍然很少。

病例描述

在此,我们重点介绍一例81岁男性患者的局限性上皮样PM病例,以及治疗过程中面临的独特挑战。盆腔肿块为7厘米,边界清晰,血管丰富,与腹壁有纤维连接。患者在初次诊断性腹腔镜检查时腹膜癌指数(PCI)为4。通过组织学确诊。进行了肿块切除并部分切除网膜。数月后,患者在随访影像检查中发现脾周区域复发。患者接受了细胞减灭术(CRS)和使用丝裂霉素C和顺铂进行60分钟的热腹腔内化疗(HIPEC),随后恢复顺利。我们的病例报告之后是对疾病病理生理学、治疗选择以及最近有前景的免疫治疗方法的文献综述。

结论

CRS和HIPEC仍然是PM患者的标准治疗方案。尽管如此,对于特定的局限性单灶性PM患者,可能需要更细致入微的治疗方法。疾病分布和负担可能会影响特定患者手术治疗的决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72b8/11399855/70a42b45a414/jgo-15-04-1939-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72b8/11399855/3fb27ae36e6d/jgo-15-04-1939-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72b8/11399855/e3a80f20d77c/jgo-15-04-1939-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72b8/11399855/e259881af78e/jgo-15-04-1939-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72b8/11399855/70a42b45a414/jgo-15-04-1939-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72b8/11399855/3fb27ae36e6d/jgo-15-04-1939-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72b8/11399855/e3a80f20d77c/jgo-15-04-1939-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72b8/11399855/e259881af78e/jgo-15-04-1939-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72b8/11399855/70a42b45a414/jgo-15-04-1939-f4.jpg

相似文献

1
The rare occurrence of unifocal peritoneal mesothelioma: a case report, literature review, and future directions.单灶性腹膜间皮瘤的罕见病例:病例报告、文献综述及未来研究方向
J Gastrointest Oncol. 2024 Aug 31;15(4):1939-1947. doi: 10.21037/jgo-24-266. Epub 2024 Aug 20.
2
Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma: Canadian practices and outcomes.细胞减灭术 (CRS) 和腹腔热灌注化疗 (HIPEC) 治疗腹膜间皮瘤:加拿大的实践和结果。
J Surg Oncol. 2023 Sep;128(4):595-603. doi: 10.1002/jso.27301. Epub 2023 May 30.
3
Response to Nivolumab followed by complete cytoreductive surgery with HIPEC resulted in long-term survival in a patient with sarcomatoid-predominant biphasic peritoneal mesothelioma. A case report.纳武单抗治疗后行完全细胞减灭术联合腹腔热灌注化疗使一名以肉瘤样为主的双相性腹膜间皮瘤患者获得长期生存。病例报告。
Int J Surg Case Rep. 2023 Jun;107:108359. doi: 10.1016/j.ijscr.2023.108359. Epub 2023 May 27.
4
[Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].1384例腹膜癌病患者接受细胞减灭术加腹腔内热灌注化疗的疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):230-239. doi: 10.3760/cma.j.cn.441530-20201110-00603.
5
Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study.腹膜间皮瘤高热腹腔化疗(HIPEC)联合化疗的影响:RENApe 研究。
Ann Surg Oncol. 2018 Oct;25(11):3271-3279. doi: 10.1245/s10434-018-6631-2. Epub 2018 Jul 5.
6
Peritoneal Mesothelioma in a High Volume Peritoneal Surface Malignancies Unit.高容量腹膜表面恶性肿瘤治疗单元中的腹膜间皮瘤
J Clin Med. 2023 Mar 15;12(6):2288. doi: 10.3390/jcm12062288.
7
Multicystic peritoneal mesothelioma treated with complete cytoreductive surgery, peritonectomy and hyperthermic intra-peritoneal chemotherapy-A case report.采用完全细胞减灭术、腹膜切除术及腹腔内热化疗治疗多囊性腹膜间皮瘤——病例报告
Int J Surg Case Rep. 2020;74:152-157. doi: 10.1016/j.ijscr.2020.07.074. Epub 2020 Aug 8.
8
Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer.胃癌腹膜转移患者在诱导化疗有反应后行腹腔热灌注化疗手术。
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S47-S56. doi: 10.21037/jgo-20-121.
9
Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent diffuse malignant peritoneal mesothelioma.复发性弥漫性恶性腹膜间皮瘤的重复细胞减灭术及腹腔内热灌注化疗
Eur J Surg Oncol. 2015 Oct;41(10):1373-8. doi: 10.1016/j.ejso.2015.07.004. Epub 2015 Jul 16.
10
Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry.细胞减灭术联合腹腔内热灌注化疗治疗腹膜间皮瘤的双相变异型是否合理?腹膜表面肿瘤国际研究组的登记结果。
Ann Surg Oncol. 2018 Mar;25(3):667-673. doi: 10.1245/s10434-017-6293-5. Epub 2017 Dec 19.

本文引用的文献

1
Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma: Canadian practices and outcomes.细胞减灭术 (CRS) 和腹腔热灌注化疗 (HIPEC) 治疗腹膜间皮瘤:加拿大的实践和结果。
J Surg Oncol. 2023 Sep;128(4):595-603. doi: 10.1002/jso.27301. Epub 2023 May 30.
2
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma.培美曲塞联合顺铂对比顺铂单药治疗恶性胸膜间皮瘤的 III 期临床研究。
J Clin Oncol. 2023 Apr 20;41(12):2125-2133. doi: 10.1200/JCO.22.02542.
3
Industry, occupation, and exposure history of mesothelioma patients in the U.S. National Mesothelioma Virtual Bank, 2006-2022.
美国国家间皮瘤虚拟银行 2006-2022 年间间皮瘤患者的工业、职业和暴露史。
Environ Res. 2023 Aug 1;230:115085. doi: 10.1016/j.envres.2022.115085. Epub 2023 Mar 23.
4
Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center.单家高容量中心行细胞减灭术联合腹腔热灌注化疗治疗腹膜间皮瘤的长期生存结果。
Ann Surg Oncol. 2023 May;30(5):2666-2675. doi: 10.1245/s10434-022-13061-3. Epub 2023 Feb 8.
5
Diffuse malignant peritoneal mesothelioma: A review.弥漫性恶性腹膜间皮瘤:综述
Front Surg. 2023 Jan 6;9:1015884. doi: 10.3389/fsurg.2022.1015884. eCollection 2022.
6
Delayed CRS-HIPEC Is Associated with Decreased Survival in Patients with Malignant Peritoneal Mesothelioma: A Markov Decision Analysis.延迟性细胞减灭术联合腹腔热灌注化疗与恶性腹膜间皮瘤患者生存率降低相关:一项马尔可夫决策分析
J Gastrointest Surg. 2023 May;27(5):995-997. doi: 10.1007/s11605-022-05540-5. Epub 2022 Nov 28.
7
Malignant peritoneal mesothelioma literature review: past, present, and future.恶性腹膜间皮瘤文献综述:过去、现在与未来。
Dig Med Res. 2022 Jun;5. doi: 10.21037/dmr-22-19. Epub 2022 Jun 30.
8
Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasis.腹腔镜评估腹膜癌指数及腹腔热灌注化疗(HIPEC)在腹膜转移患者中进行细胞减灭术的适应证的局限性。
Langenbecks Arch Surg. 2022 Jun;407(4):1667-1675. doi: 10.1007/s00423-022-02455-2. Epub 2022 Feb 2.
9
Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581.CALGB9581 对照组中 II 期结肠癌腹膜复发的潜在证据。
Am J Surg. 2022 Jul;224(1 Pt B):459-464. doi: 10.1016/j.amjsurg.2022.01.017. Epub 2022 Jan 22.
10
FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors.FAPI PET/CT在腹部和盆腔肿瘤诊断中的应用
Front Oncol. 2022 Jan 4;11:797960. doi: 10.3389/fonc.2021.797960. eCollection 2021.